Le Lézard
Classified in: Science and technology
Subject: Business Update

AEGIS Markets Record 1Q 2024 Trading Activity


AEGIS SEF, LLC ("AEGIS Markets") today provided multiple updates on its financial counterparty ("Dealer") participation, record 1Q 2024 trading activity, and value additions to its offerings.

AEGIS Markets ended 1Q24 with 28 participating Dealers. Record liquidity combined with increased volume from Commercial End Users hedging directly on the Marketplace fueled another record volume quarter. 1Q24 volume finished up 55% versus the prior year's quarter.

"Continuing adoption and growth attest directly to the value of doing business on a Marketplace," said Chris Payne, President of AEGIS Markets. "Participants can create a trade once, share it automatically with the Dealers they choose, and execute with the click of a button. Plus, everyone benefits from being easier to work with, an efficient bidding process, workflow automation loading trades into downstream systems, and trade analytics improving insights and decision making. While peers debate compliance questions, the Marketplace continues to lead with capabilities and a full commitment to make hedging markets better for commercial end users and their financial counterparties."

AEGIS Markets has also seen broad user adoption of Trade Insights, the Marketplace analytics package rolled out in 4Q23. "These hedge analytics are available automatically to all online Participants. Trade Insights saves tremendous amounts of time versus manual attempts to track data, and users are obtaining new insights regarding win/loss ratios, pricing, and performance that were not available before," said Payne.

Also notably, AEGIS Markets launched a Swap Data Repository (SDR) working group during the quarter. "AEGIS Markets can add additional value to Dealers by leveraging its position as an informed reporter to multiple SDRs," said Andrew Furman, Chief Compliance Officer for AEGIS Markets.

"Dealers are facing new challenges from changes to CFTC reporting requirements, including 49 new fields and a Commodities UPI. The working group will provide additional support for our community of Dealer back office and technology teams by helping them work efficiently to meet the next round of CFTC requirements."

About AEGIS Markets

AEGIS SEF, LLC ("AEGIS") dba AEGIS Markets, a wholly owned subsidiary of AEGIS Hedging Solutions, LLC, is registered as a Swap Execution Facility ("SEF") under the authority of the Commodity Futures Trading Commission ("CFTC") pursuant to Section 5h (7 U.S.C. 5h) of the Commodity Exchange Act ("CEA") and Part 37 (17 C.F.R. Part 37) of the CFTC Regulations thereunder. This press release is not required to be, and has not been, filed with the CFTC. The CFTC does not pass upon the adequacy or accuracy of this swap execution facility's disclosure. Consequently, the CFTC has not reviewed or approved this material. AEGIS Markets operates markets for commodities and other instruments. For more information, please visit https://www.aegis-markets.com.


These press releases may also interest you

at 18:00
BetterLife Pharma Inc. ("BetterLife" or the "Company") , an emerging biotech company focused on the development and commercialization of non-hallucinogenic LSD-based therapeutics for mental disorders, today announced that the Company intends to...

at 17:45
Celonis, the global leader in Process Mining, today announced it has appointed Mark Jacobs to the role of Senior Vice President North America Sales. As the Go-to-Market leader for North America, Jacobs will work closely with new and existing...

at 17:05
DXC Technology , a leading Fortune 500 global technology services company, today announced it will participate in the following investor conferences: J.P. Morgan's Technology, Media, & Telecom 2024 Conference ? Raul Fernandez, President and CEO, is...

at 17:05
Intercontinental Exchange, Inc. ("ICE") announced today that it is commencing a private exchange offer (the "Exchange Offer") with respect to the outstanding 3.625% Senior Notes due 2028 (the "BK Notes") issued by Black Knight InfoServ, LLC, a...

at 17:00
Spyre Therapeutics, Inc. (the "Company" or "Spyre"), a development-stage biotechnology company advancing best-in-class antibody engineering, rational therapeutic combinations, and precision medicine approaches for the treatment of Inflammatory Bowel...

at 17:00
Sentynl...



News published on and distributed by: